LH

Lancet HIV

The Lancet HIV is a medical journal covering HIV research, policy, and clinical care.

Looking to publish in Lancet HIV? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Infectious Diseases
Impact Factor 13
Quartile Q1
Open Access Type Hybrid
ISSN 2352-3018
eISSN 2352-3018
Invitation Only No
Cost Range Manuscript submission is free; open access publication is available with an article processing charge (APC).

Submission Instructions

Lancet HIV accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter Cover letter is required and must be uploaded during online submission. Detailed responses to reviewers’ comments must be provided in a cover letter with revised submissions.
Abstract Abstract (semistructured Summary) is required and must not exceed 300 words. Summary must have five paragraphs: Background, Methods, Findings, Interpretation, and Funding.
Manuscript Main text limit is 3500 words (4500 for randomised controlled trial articles). A Research in context panel is required, and a data sharing statement must appear at the end of the manuscript.
References Maximum 30 references. Vancouver style: cite sequentially as superscript numbers after punctuation; list all authors if ≤6, or first 3 then et al if ≥7.
Figures & Tables Maximum 5 figures/tables/panels. Tables must be supplied as editable Word files (separate from main text), and figures must be supplied as editable files; clinical images must not use blackout bars for anonymisation.
Reformat to Lancet HIV using Livewrite Premium

Review Article

Cover Letter Cover letter is required and must be uploaded at the “Enter Comments” stage of online submission. Revised submissions must include responses to reviewers’ comments in the cover letter.
Abstract A 150-word unstructured summary is required.
Manuscript Review Articles must be no more than 4500 words. Must include a “Search strategy and selection criteria” section.
References Maximum 75 references. Vancouver style: cite sequentially as superscript numbers; list all authors if ≤6, or first 3 then “et al” if ≥7.
Figures & Tables Up to six illustrations or tables are allowed. Figures and tables must be uploaded with the submission.
Reformat to Lancet HIV using Livewrite Premium

Editorial

Cover Letter Covering letter is required and must be uploaded during online submission (Enter Comments stage).
Abstract Abstract requirement is not specified. Abstract word limit and structure are not specified.
Manuscript No manuscript word/page limit is specified. Title page must include brief title, author details/affiliations/addresses, and corresponding author contact information.
References No maximum reference count is indicated. References must use Vancouver superscript numbering in citation order; list all authors if ≤6, or first 3 then et al if ≥7.
Figures & Tables Figures are required; no maximum figure/table count is indicated. Tables must be supplied as a separate editable Word document; figures must be ≥300 dpi and at least 107 mm wide.
Reformat to Lancet HIV using Livewrite Premium

Letter to the Editor

Cover Letter Cover letter is required and must be uploaded at the “Enter Comments” stage of online submission. Revised submissions must include detailed responses to reviewers’ comments in the cover letter.
Abstract Abstract requirement is not specified. Abstract word limit and structure are not specified.
Manuscript Letters for print publication must be ≤250 words and received within 4 weeks of the original item’s online publication; general-interest letters may be up to 400 words. Maximum of five authors is permitted.
References Maximum of five references. References must use Vancouver numbering, cited sequentially as superscript numbers after punctuation; list all authors if ≤6, or first three plus et al if ≥7.
Figures & Tables Maximum of one table or one figure. If figures are annotated, provide two separate files (annotated and non-annotated editable), and supply multi-part figures as individual parts plus a combined version.
Reformat to Lancet HIV using Livewrite Premium

Systematic Review and Meta-analysis

Cover Letter Covering letter is required and must be uploaded at the “Enter Comments” stage of online submission. Revised submissions must include detailed responses to reviewers’ comments in the covering letter.
Abstract Structured Summary is required, maximum 300 words. Summary must contain no references.
Manuscript Main text must be 3500 words (systematic reviews/meta-analyses). Manuscript must be structured as Summary, Introduction, Methods, Results, and Discussion.
References References must aim for 75, comprising included studies plus up to 30 others. Vancouver style: cite sequentially as superscript numbers; list all authors if ≤6, or first three then “et al” if ≥7.
Figures & Tables Study-selection flow chart and a table of study characteristics are required. Figures must be supplied in editable formats (eg, Word/PowerPoint or .eps/.pdf).
Reformat to Lancet HIV using Livewrite Premium

Recent Publications

Combining long-acting bNAbs for durable HIV suppression

Susan L Moir, Tae-Wook Chun

10.1016/s2352-3018(26)00098-6
View Publication

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial

Ming J Lee, Louise-Rae Cherrill, Panagiota Zacharopoulou, Simon Collins, Marcilio Fumagalli, Emanuela Falaschetti, Mohammed Altaf, Timothy Tipoe, Piyumika Godakandaarachi, Julie Fox, Alison Uriel, Amanda Clarke, Sabine Kinloch-de Loes, Sarah Pett, Marta Boffito, Gary Whitlock, Ole S Søgaard, Kyle Ring, Irvine Mangawa, Jesal Gohil, Tamara Elliott, Henrik Nielsen, Jesper Damsgaard Gunst, Chloe Orkin, Rebecca Sutherland, Lisa Hamzah, Paola Cicconi, Graham P Taylor, Jacquie Ujetz, Ishrat Jahan, Helen Brown, Nicola Robinson, Stephen Fletcher, Hanna Box, Kelly E Seaton, Georgia D Tomaras, Margaret E Ackerman, Joshua A Weiner, Anna Kaczynska, Cintia Bittar, Jill Horowitz, Michel C Nussenzweig, Marina Caskey, John Frater, Sarah Fidler

10.1016/s2352-3018(26)00059-7
View Publication

Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003–24)

Wendy P Bannister, Joanne Reekie, Lars Peters, Cristiana Oprea, Raimonda Matulionytė, Marie-Angélique De Scheerder, Alina Kryshchuk, Line Dahlerup Rasmussen, Fiona Burns, Kai Zilmer, Elżbieta Jablonowska, Christoph Boesecke, Alexandra Zagalo, Esteban Martinez, Marcel Stoeckle, János Szlávik, Jasna Topalovic Cetkovic, Georgios Adamis, Justyna D Kowalska, Daria Podlekareva

10.1016/s2352-3018(26)00052-4
View Publication

Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial

Roland Landman, Lambert Assoumou, Sidonie Lambert-Niclot, Karine Amat, Christine Katlama, Clotilde Allavena, Karine Lacombe, Olivier Bouchaud, Geoffroy Liegeon, Jade Ghosn, Severine Gibowski, Jean-Claude Alvarez, Emuri Abe, Jacqueline Capeau, Soraya Fellahi, Salima Barkat, Jean-Jacques Parienti, Laurence Morand-Joubert, Pierre De Truchis, Firouzé BANI-SADR, Gilles FORCE, Amélie CHABROL, Fabienne CABY, Claudine DUVIVIER, Myriam DIEMER, Benoît CAZENAVE, Stéphanie LANDOWSKI, Gilles PIALOUX, Nicolas VIGNIER, Sophie ABGRALL, Juliette PAVIE, Dominique SALMON-CERON, David ZUCMAN, Romain PALICH, Bénédicte LEFEBVRE, Jean-Michel MOLINA, André CABIE, Philippe MORLAT, Didier NEAU, Claire GENET, Olivia ZAEGEL-FAUCHER, Antoine BACHELARD, Jacques REYNES, Colin DESCHANVRES, Olivier BOLLENGIER-STRAGIER, Vanessa RIO, David REY, Guillaume GRAS, Pierre DELOBEL, Renaud VERDON, Lionel PIROTH, Olivier ROBINEAU, Marie-Aude KHUONG, Laurent BLUM, Christine PSOMAS, Iuliana DARASTEANU, Roland LANDMAN, Emuri ABE, Jean-Claude ALVAREZ, Karine AMAT, Lambert ASSOUMOU, Aïda BENALYCHERIF, Jacqueline CAPEAU, Martin DURACINSKI, Séverine GIBOWSKI, Mélanie JAUDON, Sidonie LAMBERT-NICLOS, Cécile MOINS, Laurence MORAND-JOUBERT, Ventzislava PETROV-SANCHEZ, Jacques REYNES, Marie ROUSSEAU, Babacar SYLLA, Pierre DE TRUCHIS, Caroline SOLAS, Edouard LHOMME, Vincent LECLERCQ, Didier LAUREILLARD, Avelin AGHOKENG, Béatrice GADALETA, Aïda BENALYCHERIF, Babacar SYLLA

10.1016/s2352-3018(26)00012-3
View Publication

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial

Sharana Mahomed, Carmen A Paez, Yunda Huang, Kelly E Seaton, Chenchen Yu, Kevin Gillespie, Maurine D Miner, Shelly T Karuna, Theresa Gamble, Jack Heptinstall, Elize Domin, Haili Tang, Lu Zhang, Fei Gao, Margaret Yacovone, Hans M L Spiegel, Julie Dumond, Maija A Anderson, Estelle Piwowar-Manning, Bonnie J Dye, India Tindale, Lori Proulx-Burns, Meg Trahey, Simbarashe Takuva, Azwidihwi Takalani, Veronique C Bailey, Spyros A Kalams, Hyman Scott, Josphat Kosgei, Sinéad Delany-Moretlwe, Sheetal Kassim, Fatima Laher, Z Mike Chirenje, Yeukai Musodza, Felix Mhlanga, Nonhlanhla Mkhize, Joshua A Weiner, Margaret E Ackerman, M Juliana McElrath, Michael N Pensiero, Lucio Gama, Dan H Barouch, Lawrence Corey, Myron S Cohen, David C Montefiori, Georgia D Tomaras, Marc Siegel, Colleen F Kelley, Margaret E. Ackerman, Maija A Anderson, Michael Archibald, Kathryn Axelrod, Veronique C. Bailey, Saman Baral, Dan H. Barouch, Gail Broder, Wairimu Chege, Shawn Chiambah, Kelvin Chiong, Z. Mike Chirenje, Myron S. Cohen, Lawrence Corey, Sinéad Delany-Moretlwe, Elize Domin, Jaiden Dumas, Julie Dumond, Bonnie J. Dye, Lucio Gama, Theresa Gamble, Fei Gao, Kevin Gillespie, Chelsea Greer, Jen Hanke, Nicholas Hastings, Jack Heptinstall, Nate Holm, Yunda Huang, Zoe Jones, Spyros A. Kalams, Geoffrey Kamau, Shelly T. Karuna, Sheetal Kassim, Colleen Kelley, Robert Klitzman, Josphat Kosgei, Gabriela Kovacikova, Fatima Laher, Judith Lucas, Jonathan Lucas, Sharana Mahomed, Anders McConachie, M. Juliana McElrath, Tara McNair, Felix Mhlanga, Maurine D. Miner, Nonhlanhla Mkhize, David C. Montefiori, Amber Moser, Yeukai Musodza, Carmen A. Paez, Michael N. Pensiero, Estelle Piwowar-Manning, Lori Proulx-Burns, Lynette Purdue, April Randhawa, Laurie Rinn, Sheetal Sawant, Hyman Scott, Kelly E. Seaton, Angelina Sharak, Marc Siegel, Hans M.L. Spiegel, Kenneth R. Stroop, Shonda E. Sumner, Azwidihwi Takalani, Simbarashe Takuva, Haili Tang, India Tindale, Georgia D. Tomaras, Meg Trahey, Lenka Tswenyana, Melissa Turner, Joshua A. Weiner, Haven Wilvich, Margaret Yacovone, Nicole Yates, Hannah Yellin, Ntando Yola, Chenchen Yu, Lu Zhang

10.1016/s2352-3018(25)00356-x
View Publication

Frequently asked questions

How long does it take to publish?

Fast-track original research Articles are peer-reviewed within 3–5 days and, if accepted, published within 10 weeks from submission.

Reformat to Lancet HIV using Livewrite Premium

Is a cover letter required?

A covering letter should be uploaded during online submission at the “Enter Comments” stage.

Reformat to Lancet HIV using Livewrite Premium

What are the publication costs?

Manuscript submission is free; open access publication is available with an article processing charge (APC).

Reformat to Lancet HIV using Livewrite Premium

Research Topics

HIV/AIDS Research and Interventions HIV, Drug Use, Sexual Risk HIV Research and Treatment HIV/AIDS drug development and treatment HIV-related health complications and treatments Adolescent Sexual and Reproductive Health Sex work and related issues HIV/AIDS Impact and Responses Pneumocystis jirovecii pneumonia detection and treatment Global Maternal and Child Health Global Public Health Policies and Epidemiology LGBTQ Health, Identity, and Policy Hepatitis C virus research Tuberculosis Research and Epidemiology Viral-associated cancers and disorders Poverty, Education, and Child Welfare Migration, Health and Trauma COVID-19 Clinical Research Studies Hepatitis B Virus Studies African Sexualities and LGBTQ+ Issues Vaccine Coverage and Hesitancy Syphilis Diagnosis and Treatment Pharmacological Effects and Toxicity Studies Cervical Cancer and HPV Research COVID-19 Impact on Reproduction

Related Journals

JO
Journal Of Infectious Diseases Oxford University Press
ID
Infectious Disease Modelling KeAi
MJ
Mediterranean Journal Of Infection Microbes And Antimicrobials Galenos Yayinevi
JO
Journal Of The American College Of Emergency Physicians Open ELSEVIER
NM
New Microbes And New Infections ELSEVIER
RP
Resuscitation Plus ELSEVIER